Total Payments
$201,131
2024 Payments
$43,398
Companies
37
Transactions
828
Medicare Patients
18,511
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$185,500 (92.2%)
Food & Beverage$15,566 (7.7%)
Education$65.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $185,500 | 7 | 92.2% |
| Food and Beverage | $15,566 | 815 | 7.7% |
| Education | $65.74 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SNAP Diagnostics LLC | $185,500 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,094 | 144 | $0 (2024) |
| Philips Electronics North America Corporation | $1,663 | 78 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,598 | 87 | $0 (2022) |
| Grifols USA, LLC | $1,420 | 74 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,414 | 63 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $1,142 | 30 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,015 | 31 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $961.42 | 34 | $0 (2024) |
| Genentech USA, Inc. | $851.25 | 88 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,398 | 57 | SNAP Diagnostics LLC ($42,300) |
| 2023 | $37,453 | 98 | SNAP Diagnostics LLC ($35,200) |
| 2022 | $1,488 | 67 | Grifols USA, LLC ($332.29) |
| 2021 | $8,930 | 104 | SNAP Diagnostics LLC ($6,750) |
| 2020 | $22,099 | 92 | SNAP Diagnostics LLC ($20,250) |
| 2019 | $29,501 | 144 | SNAP Diagnostics LLC ($27,000) |
| 2018 | $29,160 | 139 | SNAP Diagnostics LLC ($27,000) |
| 2017 | $29,103 | 127 | SNAP Diagnostics LLC ($27,000) |
All Payment Transactions
828 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Pulmonology | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Pulmonology | ||||||
| 11/05/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Pulmonology | ||||||
| 09/24/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Pulmonology | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Pulmonology | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 07/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Pulmonology | ||||||
| 07/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 4,704 | 5,823 | $1.3M | $369,252 |
| 2022 | 23 | 4,645 | 6,568 | $1.4M | $408,108 |
| 2021 | 19 | 4,557 | 5,901 | $1.3M | $405,863 |
| 2020 | 23 | 4,605 | 6,255 | $1.5M | $412,220 |
Total Patients
18,511
Total Services
24,547
Medicare Billing
$1.6M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 960 | 1,885 | $508,950 | $176,096 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 320 | 320 | $132,800 | $38,154 | 28.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 699 | 705 | $94,470 | $29,316 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 386 | 447 | $81,801 | $29,042 | 35.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 694 | 700 | $72,800 | $22,090 | 30.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 581 | 586 | $51,568 | $11,343 | 22.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 114 | 116 | $52,200 | $10,959 | 21.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 109 | 110 | $44,000 | $10,095 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $28,119 | $7,948 | 28.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 137 | 139 | $104,850 | $7,677 | 7.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 51 | $18,564 | $6,742 | 36.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 224 | 227 | $19,295 | $5,712 | 29.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 53 | 104 | $12,480 | $3,540 | 28.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 122 | 122 | $18,300 | $3,435 | 18.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 51 | 95 | $12,540 | $3,149 | 25.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 31 | 32 | $20,352 | $2,893 | 14.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 18 | $900.00 | $437.11 | 48.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 15 | 16 | $592.00 | $236.64 | 40.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 18 | 18 | $2,340 | $169.92 | 7.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 18 | 18 | $2,412 | $126.72 | 5.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $1,650 | $89.10 | 5.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 890 | 1,885 | $508,950 | $178,254 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 247 | 247 | $102,505 | $30,966 | 30.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 640 | 648 | $86,832 | $28,314 | 32.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 131 | 258 | $68,362 | $21,182 | 31.0% |
About Dr. Simmy Pinto, MD
Dr. Simmy Pinto, MD is a Sleep Medicine healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235197781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simmy Pinto, MD has received a total of $201,131 in payments from pharmaceutical and medical device companies, with $43,398 received in 2024. These payments were reported across 828 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($185,500).
As a Medicare-enrolled provider, Pinto has provided services to 18,511 Medicare beneficiaries, totaling 24,547 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Pulmonary Disease
- Location Melbourne, FL
- Active Since 05/03/2006
- Last Updated 04/23/2018
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1235197781
Products in Payments
- SNAP Diagnostics study (Device) $84,250
- Prolastin-C Liquid (Biological) $1,138
- GLASSIA (Biological) $1,109
- TRELEGY ELLIPTA (Drug) $942.14
- Wakix (Drug) $867.62
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $723.53
- OFEV (Drug) $687.24
- Esbriet (Biological) $684.79
- (8874) inCourage (Device) $605.85
- OPSUMIT MACITENTAN (Drug) $485.16
- STIOLTO RESPIMAT (Drug) $443.41
- UPTRAVI (Drug) $425.28
- BREZTRI (Drug) $416.88
- inCourage (Device) $409.92
- Wellcentive Undiv (Device) $294.75
- Prolastin-C (Biological) $281.80
- WAKIX (Drug) $274.56
- SYMBICORT (Drug) $267.03
- Yupelri (Drug) $265.62
- Arikayce (Drug) $248.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.